
Keywords: Coronary artery lesion; High-dose intravenous immunoglobulin; Kawasaki disease; Mucocutaneous lymph node syndrome; Pseudo-PelgerâHuët anomaly; CAL; Coronary artery lesion; G-CSF; Granulocyte colony-stimulating factor; IGIV; Immunoglobulin intravenous;